Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.400 AlteredExpression group BEFREE However, little is known about the expression of the vitamin D receptor (VDR) in the aging prostate and its association with the development of epithelial lesions that affect tissue homeostasis and may precede prostate tumors. 29508414 2018
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.400 AlteredExpression group BEFREE High VDR expression in prostate tumors is associated with a reduced risk of lethal cancer, suggesting a role of the vitamin D pathway in prostate cancer progression. 21537045 2011
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.400 Biomarker group CTD_human Tumor progression in the LPB-Tag transgenic model of prostate cancer is altered by vitamin D receptor and serum testosterone status. 20347977 2010
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.400 GeneticVariation group LHGDN VDR and SRD5A2 polymorphisms combine to increase risk for prostate cancer in both non-Hispanic White and Hispanic White men. 18483391 2008
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.400 AlteredExpression group LHGDN Calcitrol (1alpha,25-dihydroxyvitamin D3) inhibits androgen glucuronidation in prostate cancer cells. 18281521 2008
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.400 GeneticVariation group LHGDN Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer. 18849534 2008
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.400 Biomarker group LHGDN Association between polymorphisms of the androgen and vitamin D receptor genes with prostate cancer risk in a Mexican population. 17569297 2007
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.400 GeneticVariation group LHGDN Vitamin D receptor (VDR) gene polymorphisms and haplotypes, interactions with plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D, and prostate cancer risk. 17440943 2007
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.400 GeneticVariation group LHGDN Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer. 17932346 2007
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.400 Biomarker group LHGDN Prostate cancer susceptibility is mediated by interactions between exposure to ultraviolet radiation and polymorphisms in the 5' haplotype block of the vitamin D receptor gene. 16815628 2007
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.400 GeneticVariation group LHGDN Association of vitamin D receptor FokI polymorphism with prostate cancer risk, clinicopathological features and recurrence of prostate specific antigen after radical prostatectomy. 16708371 2006
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.400 GeneticVariation group LHGDN Vitamin D receptor polymorphisms and prostate cancer risk in Brazilian men. 15503828 2005
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.400 Biomarker group LHGDN Androgen receptor signaling and vitamin D receptor action in prostate cancer cells. 15754350 2005
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.400 GeneticVariation group LHGDN Sequence variation within the 5' regulatory regions of the vitamin D binding protein and receptor genes and prostate cancer risk. 15717311 2005
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.400 AlteredExpression group LHGDN Vitamin D receptor agonists induce prostatic acid phosphatase to reduce cell growth and HER-2 signaling in LNCaP-derived human prostate cancer cells. 16076555 2005
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.400 GeneticVariation group LHGDN Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia. 15083213 2004
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.400 AlteredExpression group LHGDN Vitamin D3 receptor/Sp1 complex is required for the induction of p27Kip1 expression by vitamin D3. 15064717 2004
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.400 GeneticVariation group LHGDN Vitamin D receptor gene polymorphisms and risk of prostate cancer: a meta-analysis. 14693728 2003
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.400 GeneticVariation group LHGDN The role of vitamin D receptor gene polymorphisms in the susceptibility to prostate cancer of a southern European population. 12181642 2002